Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to... see more

GREY:TBPMQ - Post Discussion

Tetra Bio Pharma Inc > Eye treatment news cadmium funds
View:
Post by Golddetector on Apr 27, 2022 5:20am

Eye treatment news cadmium funds

Comment by Normandt1965 on Apr 27, 2022 6:29am
Nice find Golddetector !
Comment by Albr035 on Apr 27, 2022 8:17am
Pain management, eye treatment, ... Focus on one product and get approved, jumping around tell you failed!
Comment by Golddetector on Apr 27, 2022 9:22am
This is very weird no NR. It is significant 5M free money. Is there something else coming from Tbp? Reduvo Din? QIXLEEF? They want to announce 1st? Below is the link for Tbp research for eye drop and earlier partnership 2years ago with Altus  https://ca.paidpromotionalmessages.com/companies/news/948447/tetra-bio-pharma-to-reactivate-clinical-trial-to-evaluate-veterinary-drug-ppp-003v-to ...more  
Comment by NSX001 on Apr 27, 2022 9:45am
Hi Golddetector, I don't think all of the amounts are being provided by the Quebec government CQDM. It sounds to me like TBP is one of those funders along with Altus Formulation. Below is the first paragraph from the release, with key point highlights. "MONTREAL, April 28 2022 – CQDM is proud to announce the launch of a $5,254,895 project exploring new class of drugs to treat eye ...more  
Comment by Golddetector on Apr 27, 2022 9:58am
CQDM is arranging that I guess. It is non profit organization. Not sure if tetra is here bcz of their money. Most likely is technical expertise. It will be good if get more details. I was waiting for a nr to provide more details but I guess we have to wait.
Comment by NSX001 on Apr 27, 2022 10:30am
It seems a little odd that no info has been released to TBP shareholders. Your right though, It appears that CQDM is the front organization on this. Funding seems to be coming from: MEI ($1,268,682.00), a very specific amount. Mitacs ? NSERC ? Altus Formulation ? & Tetra Biopharma ? Need more information before we celebrate this news. NSX001
Comment by Golddetector on Apr 27, 2022 1:44pm
There are two dates on that news April 26 And April 28 maybe it was planned for tomorrow. We shall see I guess  https://cqdm.org/news-and-events/cqdm-funds-an-innovative-project-with-altus-formulation-and-tetra-bio-pharma-to-develop-first-in-class-treatments-for-ocular-inflammation/
Comment by Normandt1965 on Apr 27, 2022 1:50pm
It's strange
Comment by Savage97 on Apr 27, 2022 11:41am
!!!!!!!!!!!FANTASTIC NEWS!!!!!!!!!!!!  Investors will continue backing TBP as long as they keep succeeding with their clinical trials.  $$$
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities